 | • レポートコード：QAF27744 • 出版社/出版日：QYResearch / 2021年4月8日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のインターフェロンα-2aバイオシミラー市場について種類別（長持ちタイプ、一般タイプ）、用途別（C型肝炎、B型肝炎、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・インターフェロンα-2aバイオシミラー市場の概要 ・世界の主要地域別インターフェロンα-2aバイオシミラー市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のインターフェロンα-2aバイオシミラー市場規模2016-2021：種類別（長持ちタイプ、一般タイプ） ・世界のインターフェロンα-2aバイオシミラー市場予測2012-2027：種類別（長持ちタイプ、一般タイプ） ・世界のインターフェロンα-2aバイオシミラー市場規模2016-2021：用途別（C型肝炎、B型肝炎、その他） ・世界のインターフェロンα-2aバイオシミラー市場予測2012-2027：用途別（C型肝炎、B型肝炎、その他） ・インターフェロンα-2aバイオシミラーのアメリカ市場規模と予測2016-2021 ・インターフェロンα-2aバイオシミラーのヨーロッパ市場規模と予測2016-2021 ・インターフェロンα-2aバイオシミラーの中国市場規模と予測2016-2021 ・インターフェロンα-2aバイオシミラーの日本市場規模と予測2016-2021 ・インターフェロンα-2aバイオシミラーの東南アジア市場規模と予測2016-2021 ・インターフェロンα-2aバイオシミラーのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、Biosidus、Zydus Cadila、Nanogen、Amega Biotech、Rhein Minapharm Biogenetics、PROBIOMED、3sbio） ・インターフェロンα-2aバイオシミラーの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インターフェロンα-2aバイオシミラーの市場動向・機会・課題 ・調査の結論 |
Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
The global average price of Interferon Alpha-2a Biosimilar is in the decreasing trend, from 186.78 USD/Unit in 2013 to 64.67 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Interferon Alpha-2a Biosimilar includes ordinary type and long-lasting type, and the proportion of ordinary type in 2017 is about 64%, and the proportion is in increasing trend from 2013 to 2017.
Interferon Alpha-2a Biosimilar is widely used for hepatitis C, hepatitis B and other diseases. The most proportion of Interferon Alpha-2a Biosimilar is used for hepatitis C, and the proportion in 2017 is 46%.
Europe is the largest supplier of Interferon Alpha-2a Biosimilar, with a production market share nearly 70% in 2017.
South America is the largest consumption place, with a consumption market share nearly 26% in 2017. Following South America, Europe is the second largest consumption place with the consumption market share of 22%.
Market competition is not intense. Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Interferon Alpha-2a Biosimilar Market
The global Interferon Alpha-2a Biosimilar market was valued at US$ 241 in 2020 and will reach US$ 119.8 million by the end of 2027, growing at a CAGR of -11.0% during 2022-2027.
Global Interferon Alpha-2a Biosimilar Scope and Market Size
The global Interferon Alpha-2a Biosimilar market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Interferon Alpha-2a Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Long-lasting Type
Ordinary Type
Segment by Application
Hepatitis C
Hepatitis B
Others
The Interferon Alpha-2a Biosimilar market is analysed and market size information is provided by regions (countries). Segment by Application, the Interferon Alpha-2a Biosimilar market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Roche
Biosidus
Zydus Cadila
Nanogen
Amega Biotech
Rhein Minapharm Biogenetics
PROBIOMED
3sbio
1 Interferon Alpha-2a Biosimilar Market Overview
1.1 Interferon Alpha-2a Biosimilar Product Scope
1.2 Interferon Alpha-2a Biosimilar Segment by Type
1.2.1 Global Interferon Alpha-2a Biosimilar Sales by Type (2016 & 2021 & 2027)
1.2.2 Long-lasting Type
1.2.3 Ordinary Type
1.3 Interferon Alpha-2a Biosimilar Segment by Application
1.3.1 Global Interferon Alpha-2a Biosimilar Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hepatitis C
1.3.3 Hepatitis B
1.3.4 Others
1.4 Interferon Alpha-2a Biosimilar Market Estimates and Forecasts (2016-2027)
1.4.1 Global Interferon Alpha-2a Biosimilar Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Interferon Alpha-2a Biosimilar Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Interferon Alpha-2a Biosimilar Price Trends (2016-2027)
2 Interferon Alpha-2a Biosimilar Estimates and Forecasts by Region
2.1 Global Interferon Alpha-2a Biosimilar Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Interferon Alpha-2a Biosimilar Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Interferon Alpha-2a Biosimilar Sales Market Share by Region (2016-2021)
2.2.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Region (2016-2021)
2.3 Global Interferon Alpha-2a Biosimilar Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Interferon Alpha-2a Biosimilar Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Interferon Alpha-2a Biosimilar Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Interferon Alpha-2a Biosimilar Estimates and Projections (2016-2027)
2.4.2 Europe Interferon Alpha-2a Biosimilar Estimates and Projections (2016-2027)
2.4.3 China Interferon Alpha-2a Biosimilar Estimates and Projections (2016-2027)
2.4.4 Japan Interferon Alpha-2a Biosimilar Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Interferon Alpha-2a Biosimilar Estimates and Projections (2016-2027)
2.4.6 India Interferon Alpha-2a Biosimilar Estimates and Projections (2016-2027)
3 Global Interferon Alpha-2a Biosimilar Competition Landscape by Players
3.1 Global Top Interferon Alpha-2a Biosimilar Players by Sales (2016-2021)
3.2 Global Top Interferon Alpha-2a Biosimilar Players by Revenue (2016-2021)
3.3 Global Interferon Alpha-2a Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Interferon Alpha-2a Biosimilar as of 2020)
3.4 Global Interferon Alpha-2a Biosimilar Average Price by Company (2016-2021)
3.5 Manufacturers Interferon Alpha-2a Biosimilar Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Interferon Alpha-2a Biosimilar Market Size by Type
4.1 Global Interferon Alpha-2a Biosimilar Historic Market Review by Type (2016-2021)
4.1.1 Global Interferon Alpha-2a Biosimilar Sales Market Share by Type (2016-2021)
4.1.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Type (2016-2021)
4.1.3 Global Interferon Alpha-2a Biosimilar Price by Type (2016-2021)
4.2 Global Interferon Alpha-2a Biosimilar Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Interferon Alpha-2a Biosimilar Sales Forecast by Type (2022-2027)
4.2.2 Global Interferon Alpha-2a Biosimilar Revenue Forecast by Type (2022-2027)
4.2.3 Global Interferon Alpha-2a Biosimilar Price Forecast by Type (2022-2027)
5 Global Interferon Alpha-2a Biosimilar Market Size by Application
5.1 Global Interferon Alpha-2a Biosimilar Historic Market Review by Application (2016-2021)
5.1.1 Global Interferon Alpha-2a Biosimilar Sales Market Share by Application (2016-2021)
5.1.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Application (2016-2021)
5.1.3 Global Interferon Alpha-2a Biosimilar Price by Application (2016-2021)
5.2 Global Interferon Alpha-2a Biosimilar Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Interferon Alpha-2a Biosimilar Sales Forecast by Application (2022-2027)
5.2.2 Global Interferon Alpha-2a Biosimilar Revenue Forecast by Application (2022-2027)
5.2.3 Global Interferon Alpha-2a Biosimilar Price Forecast by Application (2022-2027)
6 North America Interferon Alpha-2a Biosimilar Market Facts & Figures
6.1 North America Interferon Alpha-2a Biosimilar Sales by Company
6.1.1 North America Interferon Alpha-2a Biosimilar Sales by Company (2016-2021)
6.1.2 North America Interferon Alpha-2a Biosimilar Revenue by Company (2016-2021)
6.2 North America Interferon Alpha-2a Biosimilar Sales Breakdown by Type
6.2.1 North America Interferon Alpha-2a Biosimilar Sales Breakdown by Type (2016-2021)
6.2.2 North America Interferon Alpha-2a Biosimilar Sales Breakdown by Type (2022-2027)
6.3 North America Interferon Alpha-2a Biosimilar Sales Breakdown by Application
6.3.1 North America Interferon Alpha-2a Biosimilar Sales Breakdown by Application (2016-2021)
6.3.2 North America Interferon Alpha-2a Biosimilar Sales Breakdown by Application (2022-2027)
7 Europe Interferon Alpha-2a Biosimilar Market Facts & Figures
7.1 Europe Interferon Alpha-2a Biosimilar Sales by Company
7.1.1 Europe Interferon Alpha-2a Biosimilar Sales by Company (2016-2021)
7.1.2 Europe Interferon Alpha-2a Biosimilar Revenue by Company (2016-2021)
7.2 Europe Interferon Alpha-2a Biosimilar Sales Breakdown by Type
7.2.1 Europe Interferon Alpha-2a Biosimilar Sales Breakdown by Type (2016-2021)
7.2.2 Europe Interferon Alpha-2a Biosimilar Sales Breakdown by Type (2022-2027)
7.3 Europe Interferon Alpha-2a Biosimilar Sales Breakdown by Application
7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)
8 China Interferon Alpha-2a Biosimilar Market Facts & Figures
8.1 China Interferon Alpha-2a Biosimilar Sales by Company
8.1.1 China Interferon Alpha-2a Biosimilar Sales by Company (2016-2021)
8.1.2 China Interferon Alpha-2a Biosimilar Revenue by Company (2016-2021)
8.2 China Interferon Alpha-2a Biosimilar Sales Breakdown by Type
8.2.1 China Interferon Alpha-2a Biosimilar Sales Breakdown by Type (2016-2021)
8.2.2 China Interferon Alpha-2a Biosimilar Sales Breakdown by Type (2022-2027)
8.3 China Interferon Alpha-2a Biosimilar Sales Breakdown by Application
8.3.1 China 246 Sales Breakdown by Application (2016-2021)
8.3.2 China 246 Sales Breakdown by Application (2022-2027)
9 Japan Interferon Alpha-2a Biosimilar Market Facts & Figures
9.1 Japan Interferon Alpha-2a Biosimilar Sales by Company
9.1.1 Japan Interferon Alpha-2a Biosimilar Sales by Company (2016-2021)
9.1.2 Japan Interferon Alpha-2a Biosimilar Revenue by Company (2016-2021)
9.2 Japan Interferon Alpha-2a Biosimilar Sales Breakdown by Type
9.2.1 Japan Interferon Alpha-2a Biosimilar Sales Breakdown by Type (2016-2021)
9.2.2 Japan Interferon Alpha-2a Biosimilar Sales Breakdown by Type (2022-2027)
9.3 Japan Interferon Alpha-2a Biosimilar Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Interferon Alpha-2a Biosimilar Market Facts & Figures
10.1 Southeast Asia Interferon Alpha-2a Biosimilar Sales by Company
10.1.1 Southeast Asia Interferon Alpha-2a Biosimilar Sales by Company (2016-2021)
10.1.2 Southeast Asia Interferon Alpha-2a Biosimilar Revenue by Company (2016-2021)
10.2 Southeast Asia Interferon Alpha-2a Biosimilar Sales Breakdown by Type
10.2.1 Southeast Asia Interferon Alpha-2a Biosimilar Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Interferon Alpha-2a Biosimilar Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Interferon Alpha-2a Biosimilar Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Interferon Alpha-2a Biosimilar Market Facts & Figures
11.1 India Interferon Alpha-2a Biosimilar Sales by Company
11.1.1 India Interferon Alpha-2a Biosimilar Sales by Company (2016-2021)
11.1.2 India Interferon Alpha-2a Biosimilar Revenue by Company (2016-2021)
11.2 India Interferon Alpha-2a Biosimilar Sales Breakdown by Type
11.2.1 India Interferon Alpha-2a Biosimilar Sales Breakdown by Type (2016-2021)
11.2.2 India Interferon Alpha-2a Biosimilar Sales Breakdown by Type (2022-2027)
11.3 India Interferon Alpha-2a Biosimilar Sales Breakdown by Application
11.3.1 India Interferon Alpha-2a Biosimilar Sales Breakdown by Application (2016-2021)
11.3.2 India Interferon Alpha-2a Biosimilar Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Interferon Alpha-2a Biosimilar Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Interferon Alpha-2a Biosimilar Products Offered
12.1.5 Roche Recent Development
12.2 Biosidus
12.2.1 Biosidus Corporation Information
12.2.2 Biosidus Business Overview
12.2.3 Biosidus Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Biosidus Interferon Alpha-2a Biosimilar Products Offered
12.2.5 Biosidus Recent Development
12.3 Zydus Cadila
12.3.1 Zydus Cadila Corporation Information
12.3.2 Zydus Cadila Business Overview
12.3.3 Zydus Cadila Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Zydus Cadila Interferon Alpha-2a Biosimilar Products Offered
12.3.5 Zydus Cadila Recent Development
12.4 Nanogen
12.4.1 Nanogen Corporation Information
12.4.2 Nanogen Business Overview
12.4.3 Nanogen Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Nanogen Interferon Alpha-2a Biosimilar Products Offered
12.4.5 Nanogen Recent Development
12.5 Amega Biotech
12.5.1 Amega Biotech Corporation Information
12.5.2 Amega Biotech Business Overview
12.5.3 Amega Biotech Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Amega Biotech Interferon Alpha-2a Biosimilar Products Offered
12.5.5 Amega Biotech Recent Development
12.6 Rhein Minapharm Biogenetics
12.6.1 Rhein Minapharm Biogenetics Corporation Information
12.6.2 Rhein Minapharm Biogenetics Business Overview
12.6.3 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Products Offered
12.6.5 Rhein Minapharm Biogenetics Recent Development
12.7 PROBIOMED
12.7.1 PROBIOMED Corporation Information
12.7.2 PROBIOMED Business Overview
12.7.3 PROBIOMED Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.7.4 PROBIOMED Interferon Alpha-2a Biosimilar Products Offered
12.7.5 PROBIOMED Recent Development
12.8 3sbio
12.8.1 3sbio Corporation Information
12.8.2 3sbio Business Overview
12.8.3 3sbio Interferon Alpha-2a Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.8.4 3sbio Interferon Alpha-2a Biosimilar Products Offered
12.8.5 3sbio Recent Development
13 Interferon Alpha-2a Biosimilar Manufacturing Cost Analysis
13.1 Interferon Alpha-2a Biosimilar Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Interferon Alpha-2a Biosimilar
13.4 Interferon Alpha-2a Biosimilar Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Interferon Alpha-2a Biosimilar Distributors List
14.3 Interferon Alpha-2a Biosimilar Customers
15 Market Dynamics
15.1 Interferon Alpha-2a Biosimilar Market Trends
15.2 Interferon Alpha-2a Biosimilar Drivers
15.3 Interferon Alpha-2a Biosimilar Market Challenges
15.4 Interferon Alpha-2a Biosimilar Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Interferon Alpha-2a Biosimilar Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Interferon Alpha-2a Biosimilar Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Interferon Alpha-2a Biosimilar Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Interferon Alpha-2a Biosimilar Sales (MT) by Region (2016-2021)
Table 5. Global Interferon Alpha-2a Biosimilar Sales Market Share by Region (2016-2021)
Table 6. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Interferon Alpha-2a Biosimilar Revenue Share by Region (2016-2021)
Table 8. Global Interferon Alpha-2a Biosimilar Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Interferon Alpha-2a Biosimilar Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Interferon Alpha-2a Biosimilar Revenue Share Forecast by Region (2022-2027)
Table 12. Global Interferon Alpha-2a Biosimilar Sales (MT) of Key Companies (2016-2021)
Table 13. Global Interferon Alpha-2a Biosimilar Sales Share by Company (2016-2021)
Table 14. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Interferon Alpha-2a Biosimilar Revenue Share by Company (2016-2021)
Table 16. Global Interferon Alpha-2a Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interferon Alpha-2a Biosimilar as of 2020)
Table 17. Global Interferon Alpha-2a Biosimilar Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Interferon Alpha-2a Biosimilar Manufacturing Sites and Area Served
Table 19. Manufacturers Interferon Alpha-2a Biosimilar Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Interferon Alpha-2a Biosimilar Sales (MT) by Type (2016-2021)
Table 22. Global Interferon Alpha-2a Biosimilar Sales Share by Type (2016-2021)
Table 23. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Interferon Alpha-2a Biosimilar Price (USD/Kg) by Type (2016-2021)
Table 25. Global Interferon Alpha-2a Biosimilar Sales Share by Type (2022-2027)
Table 26. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Interferon Alpha-2a Biosimilar Revenue Share by Type (2022-2027)
Table 28. Global Interferon Alpha-2a Biosimilar Price (USD/Kg) by Type (2022-2027)
Table 29. Global Interferon Alpha-2a Biosimilar Sales (MT) by Application (2016-2021)
Table 30. Global Interferon Alpha-2a Biosimilar Sales Share by Application (2016-2021)
Table 31. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Interferon Alpha-2a Biosimilar Price (USD/Kg) by Application (2016-2021)
Table 33. Global Interferon Alpha-2a Biosimilar Sales (MT) by Application (2022-2027)
Table 34. Global Interferon Alpha-2a Biosimilar Sales Share by Application (2022-2027)
Table 35. Global Interferon Alpha-2a Biosimilar Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Interferon Alpha-2a Biosimilar Revenue Share by Application (2022-2027)
Table 37. Global Interferon Alpha-2a Biosimilar Price (USD/Kg) by Application (2022-2027)
Table 38. North America Interferon Alpha-2a Biosimilar Sales (MT) by Company (2016-2021)
Table 39. North America Interferon Alpha-2a Biosimilar Sales Market Share by Company (2016-2021)
Table 40. North America Interferon Alpha-2a Biosimilar Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Interferon Alpha-2a Biosimilar Revenue Market Share by Company (2016-2021)
Table 42. North America Interferon Alpha-2a Biosimilar Sales by Type (2016-2021) & (MT)
Table 43. North America Interferon Alpha-2a Biosimilar Sales Market Share by Type (2016-2021)
Table 44. North America Interferon Alpha-2a Biosimilar Sales by Type (2022-2027) & (MT)
Table 45. North America Interferon Alpha-2a Biosimilar Sales Market Share by Type (2022-2027)
Table 46. North America Interferon Alpha-2a Biosimilar Sales by Application (2016-2021) & (MT)
Table 47. North America Interferon Alpha-2a Biosimilar Sales Market Share by Application (2016-2021)
Table 48. North America Interferon Alpha-2a Biosimilar Sales by Application (2022-2027) & (MT)
Table 49. North America Interferon Alpha-2a Biosimilar Sales Market Share by Application (2022-2027)
Table 50. Europe Interferon Alpha-2a Biosimilar Sales (MT) by Company (2016-2021)
Table 51. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Company (2016-2021)
Table 52. Europe Interferon Alpha-2a Biosimilar Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Interferon Alpha-2a Biosimilar Revenue Market Share by Company (2016-2021)
Table 54. Europe Interferon Alpha-2a Biosimilar Sales by Type (2016-2021) & (MT)
Table 55. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Type (2016-2021)
Table 56. Europe Interferon Alpha-2a Biosimilar Sales by Type (2022-2027) & (MT)
Table 57. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Type (2022-2027)
Table 58. Europe Interferon Alpha-2a Biosimilar Sales by Application (2016-2021) & (MT)
Table 59. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Application (2016-2021)
Table 60. Europe Interferon Alpha-2a Biosimilar Sales by Application (2022-2027) & (MT)
Table 61. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Application (2022-2027)
Table 62. China Interferon Alpha-2a Biosimilar Sales (MT) by Company (2016-2021)
Table 63. China Interferon Alpha-2a Biosimilar Sales Market Share by Company (2016-2021)
Table 64. China Interferon Alpha-2a Biosimilar Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Interferon Alpha-2a Biosimilar Revenue Market Share by Company (2016-2021)
Table 66. China Interferon Alpha-2a Biosimilar Sales by Type (2016-2021) & (MT)
Table 67. China Interferon Alpha-2a Biosimilar Sales Market Share by Type (2016-2021)
Table 68. China Interferon Alpha-2a Biosimilar Sales by Type (2022-2027) & (MT)
Table 69. China Interferon Alpha-2a Biosimilar Sales Market Share by Type (2022-2027)
Table 70. China Interferon Alpha-2a Biosimilar Sales by Application (2016-2021) & (MT)
Table 71. China Interferon Alpha-2a Biosimilar Sales Market Share by Application (2016-2021)
Table 72. China Interferon Alpha-2a Biosimilar Sales by Application (2022-2027) & (MT)
Table 73. China Interferon Alpha-2a Biosimilar Sales Market Share by Application (2022-2027)
Table 74. Japan Interferon Alpha-2a Biosimilar Sales (MT) by Company (2016-2021)
Table 75. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Company (2016-2021)
Table 76. Japan Interferon Alpha-2a Biosimilar Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Interferon Alpha-2a Biosimilar Revenue Market Share by Company (2016-2021)
Table 78. Japan Interferon Alpha-2a Biosimilar Sales by Type (2016-2021) & (MT)
Table 79. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Type (2016-2021)
Table 80. Japan Interferon Alpha-2a Biosimilar Sales by Type (2022-2027) & (MT)
Table 81. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Type (2022-2027)
Table 82. Japan Interferon Alpha-2a Biosimilar Sales by Application (2016-2021) & (MT)
Table 83. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Application (2016-2021)
Table 84. Japan Interferon Alpha-2a Biosimilar Sales by Application (2022-2027) & (MT)
Table 85. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Interferon Alpha-2a Biosimilar Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Interferon Alpha-2a Biosimilar Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Interferon Alpha-2a Biosimilar Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Interferon Alpha-2a Biosimilar Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Interferon Alpha-2a Biosimilar Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Interferon Alpha-2a Biosimilar Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Interferon Alpha-2a Biosimilar Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Application (2022-2027)
Table 98. India Interferon Alpha-2a Biosimilar Sales (MT) by Company (2016-2021)
Table 99. India Interferon Alpha-2a Biosimilar Sales Market Share by Company (2016-2021)
Table 100. India Interferon Alpha-2a Biosimilar Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Interferon Alpha-2a Biosimilar Revenue Market Share by Company (2016-2021)
Table 102. India Interferon Alpha-2a Biosimilar Sales by Type (2016-2021) & (MT)
Table 103. India Interferon Alpha-2a Biosimilar Sales Market Share by Type (2016-2021)
Table 104. India Interferon Alpha-2a Biosimilar Sales by Type (2022-2027) & (MT)
Table 105. India Interferon Alpha-2a Biosimilar Sales Market Share by Type (2022-2027)
Table 106. India Interferon Alpha-2a Biosimilar Sales by Application (2016-2021) & (MT)
Table 107. India Interferon Alpha-2a Biosimilar Sales Market Share by Application (2016-2021)
Table 108. India Interferon Alpha-2a Biosimilar Sales by Application (2022-2027) & (MT)
Table 109. India Interferon Alpha-2a Biosimilar Sales Market Share by Application (2022-2027)
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Roche Interferon Alpha-2a Biosimilar Product
Table 114. Roche Recent Development
Table 115. Biosidus Corporation Information
Table 116. Biosidus Description and Business Overview
Table 117. Biosidus Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Biosidus Interferon Alpha-2a Biosimilar Product
Table 119. Biosidus Recent Development
Table 120. Zydus Cadila Corporation Information
Table 121. Zydus Cadila Description and Business Overview
Table 122. Zydus Cadila Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Zydus Cadila Interferon Alpha-2a Biosimilar Product
Table 124. Zydus Cadila Recent Development
Table 125. Nanogen Corporation Information
Table 126. Nanogen Description and Business Overview
Table 127. Nanogen Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Nanogen Interferon Alpha-2a Biosimilar Product
Table 129. Nanogen Recent Development
Table 130. Amega Biotech Corporation Information
Table 131. Amega Biotech Description and Business Overview
Table 132. Amega Biotech Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Amega Biotech Interferon Alpha-2a Biosimilar Product
Table 134. Amega Biotech Recent Development
Table 135. Rhein Minapharm Biogenetics Corporation Information
Table 136. Rhein Minapharm Biogenetics Description and Business Overview
Table 137. Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Product
Table 139. Rhein Minapharm Biogenetics Recent Development
Table 140. PROBIOMED Corporation Information
Table 141. PROBIOMED Description and Business Overview
Table 142. PROBIOMED Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. PROBIOMED Interferon Alpha-2a Biosimilar Product
Table 144. PROBIOMED Recent Development
Table 145. 3sbio Corporation Information
Table 146. 3sbio Interferon Alpha-2a Biosimilar Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. 3sbio Description and Business Overview
Table 148. 3sbio Interferon Alpha-2a Biosimilar Product
Table 149. 3sbio Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Interferon Alpha-2a Biosimilar Distributors List
Table 153. Interferon Alpha-2a Biosimilar Customers List
Table 154. Interferon Alpha-2a Biosimilar Market Trends
Table 155. Interferon Alpha-2a Biosimilar Market Drivers
Table 156. Interferon Alpha-2a Biosimilar Market Challenges
Table 157. Interferon Alpha-2a Biosimilar Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Interferon Alpha-2a Biosimilar Product Picture
Figure 2. Global Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Interferon Alpha-2a Biosimilar Sales Market Share by Application in 2021 & 2027
Figure 6. Hepatitis C Examples
Figure 7. Hepatitis B Examples
Figure 8. Others Examples
Figure 9. Global Interferon Alpha-2a Biosimilar Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Interferon Alpha-2a Biosimilar Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Interferon Alpha-2a Biosimilar Sales (MT) Growth Rate (2016-2027)
Figure 12. Global Interferon Alpha-2a Biosimilar Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 13. Global Interferon Alpha-2a Biosimilar Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Interferon Alpha-2a Biosimilar Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Interferon Alpha-2a Biosimilar Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Interferon Alpha-2a Biosimilar Sales (MT) Growth Rate (2016-2027)
Figure 17. Europe Interferon Alpha-2a Biosimilar Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Interferon Alpha-2a Biosimilar Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Interferon Alpha-2a Biosimilar Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Interferon Alpha-2a Biosimilar Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Interferon Alpha-2a Biosimilar Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Interferon Alpha-2a Biosimilar Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Interferon Alpha-2a Biosimilar Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Interferon Alpha-2a Biosimilar Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Interferon Alpha-2a Biosimilar Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Interferon Alpha-2a Biosimilar Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Interferon Alpha-2a Biosimilar Players Market Share by Revenue in Interferon Alpha-2a Biosimilar: 2016 & 2020
Figure 28. Interferon Alpha-2a Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Interferon Alpha-2a Biosimilar Revenue Share by Type (2016-2021)
Figure 30. Global Interferon Alpha-2a Biosimilar Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Interferon Alpha-2a Biosimilar Revenue Share by Application (2016-2021)
Figure 32. Global Interferon Alpha-2a Biosimilar Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2020
Figure 34. North America Interferon Alpha-2a Biosimilar Sales Market Share by Application in 2020
Figure 35. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2020
Figure 36. Europe Interferon Alpha-2a Biosimilar Sales Market Share by Application in 2020
Figure 37. China Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2020
Figure 38. China Interferon Alpha-2a Biosimilar Sales Market Share by Application in 2020
Figure 39. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2020
Figure 40. Japan Interferon Alpha-2a Biosimilar Sales Market Share by Application in 2020
Figure 41. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2020
Figure 42. Southeast Asia Interferon Alpha-2a Biosimilar Sales Market Share by Application in 2020
Figure 43. India Interferon Alpha-2a Biosimilar Sales Market Share by Type in 2020
Figure 44. India Interferon Alpha-2a Biosimilar Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Interferon Alpha-2a Biosimilar
Figure 47. Manufacturing Process Analysis of Interferon Alpha-2a Biosimilar
Figure 48. Interferon Alpha-2a Biosimilar Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
インターフェロンアルファ-2bバイオシミラーのグローバル市場調査 2019年 The global Interferon Alpha-2b Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Interferon Alpha-2b Biosimilar volume and value at global level, regional level and company level. From a gl…- インターフェロンベータ-1aのグローバル市場調査 2019年 The global Interferon Beta-1a market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Interferon Beta-1a volume and value at global level, regional level and company level. From a global perspective, this r…
- 世界のβ-インターフェロン市場規模・現状・予測（2021年-2027年） β-Interferon is a type I interferon. It is produced by various cells such as fibroblasts after induction by viruses and nucleic acids. Market Analysis and Insights: Global β-Interferon Market The global β-Interferon market size is projected to reach US$ XX million by 2027, from US$ XX million in 202…
- バイオシミラー薬のグローバル市場2021 Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or a…
- バイオシミラーモノクローナル抗体のグローバル市場2021 Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are calle…